@article{85212572109f4d219b0f6d071717bb03,
title = "Outcomes of rare patients with a primary cutaneous CD30(+) lymphoproliferative disorder developing extracutaneous disease",
keywords = "brentuximab vedotin, classification, diagnosis, eortc, guidelines, iscl, large-cell lymphoma, papulosis, DIAGNOSIS, PAPULOSIS, EORTC, GUIDELINES, BRENTUXIMAB VEDOTIN, CLASSIFICATION, LARGE-CELL LYMPHOMA, ISCL",
author = "R.C. Melchers and R. Willemze and J.S.P. Vermaat and P.M. Jansen and L.A. Daniels and H. Putter and M.W. Bekkenk and {de Haas}, E.R.M. and B. Horvath and {van Rossum}, M.M. and C.J.G. Sanders and J.C.J.M. Veraart and M.H. Vermeer and K.D. Quint",
year = "2020",
month = mar,
day = "5",
doi = "10.1182/blood.2019002799",
language = "English",
volume = "135",
pages = "769--773",
journal = "Blood",
issn = "0006-4971",
publisher = "Elsevier B.V.",
number = "10",
}